OOIR: Observatory of International Research

Papers

(The H4-Index of Gut Microbes is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Gut microbiota and tuberculosis infection: interaction and therapeutic potential	276
Late-onset sepsis treatment in very preterm infants alters longitudinal microbiome trajectory with lower abundance of Bifidobacterium despite probiotic supplementation	253
The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics	250
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	210
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	206
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	161
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	155
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	141
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	131
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	127
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	126
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	119
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	113
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	110
Modeling spatial interaction networks of the gut microbiota	109
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	108
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	101
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	101
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	100
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	100
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	92
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	91
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	90
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	87
Effect of diet on the evolution of gut commensal bacteria	86

Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	86
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	85
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	84
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	84
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	83
Intestinal bacteria and colorectal cancer: etiology and treatment	82
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	81
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	81
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	81
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	80
Gut microbiota and radiation-induced injury: mechanistic insights and microbial therapies	80
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer	79
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	79
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	77
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	74
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	74
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	74
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice	74
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	72
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	71
Antidepressant drugs promote the spread of broad-host-range plasmid in mouse and human gut microbiota	71
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	71
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	71
In vivo systematic analysis of microbiota-prebiotic crosstalk reveals a synbiotic that effectively ameliorates DSS-induced colitis in mice	71
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	70
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	70
Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism	69
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	68
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	66
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	64
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	64
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	64
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	63
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	63
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	61
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	61
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	61
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	61